ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.277,07
0,52%
S&P 500
5.543,22
0,00%
Dow Jones
40.563,06
0,00%
Euro vs US Dollar
1,09949
0,20%
Bitcoin
58.576,82
1,80%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) News

AXGN

Axogen (AXGN)

Axogen Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AXGN
DatumZeitQuelleÜberschriftSymbolFirma
13/08/202423h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
13/08/202422h18GlobeNewswire Inc.CytoSorbents Appoints Peter J. Mariani Chief Financial OfficerNASDAQ:AXGNAxogen Inc
12/08/202416h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
09/08/202422h36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
09/08/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
09/08/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
09/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
08/08/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXGNAxogen Inc
08/08/202413h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
08/08/202413h05GlobeNewswire Inc.Axogen, Inc. Announces New Leadership AppointmentsNASDAQ:AXGNAxogen Inc
08/08/202413h00GlobeNewswire Inc.Axogen, Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
23/07/202413h00GlobeNewswire Inc.Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024NASDAQ:AXGNAxogen Inc
01/07/202413h00GlobeNewswire Inc.Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
24/06/202413h00GlobeNewswire Inc.Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
11/06/202400h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
07/06/202422h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
06/06/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
28/05/202422h30GlobeNewswire Inc.Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in VandaliaNASDAQ:AXGNAxogen Inc
16/05/202413h00GlobeNewswire Inc.Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
14/05/202413h00GlobeNewswire Inc.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceNASDAQ:AXGNAxogen Inc
02/05/202413h00GlobeNewswire Inc.Axogen, Inc Reports First Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
29/04/202422h50GlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
16/04/202413h00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
TG
TUI1
Tui
USOTC
RHHBY
Roche (QX)
COIN
AVAXUSD
Avalanche
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
COIN
ADAUSD
Cardano
COIN
ETHUSD
Ethereum
COIN
SOLUSD
Solana
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
TG
RHM
Rheinmetall
CCOM
SILVER
SILVER
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten